Product NDC: | 24090-721 |
Proprietary Name: | Suprenza |
Non Proprietary Name: | phentermine hydrochloride |
Active Ingredient(s): | 30 mg/1 & nbsp; phentermine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24090-721 |
Labeler Name: | Akrimax Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA202088 |
Marketing Category: | NDA |
Start Marketing Date: | 20121214 |
Package NDC: | 24090-721-85 |
Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (24090-721-85) |
NDC Code | 24090-721-85 |
Proprietary Name | Suprenza |
Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (24090-721-85) |
Product NDC | 24090-721 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | phentermine hydrochloride |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20121214 |
Marketing Category Name | NDA |
Labeler Name | Akrimax Pharmaceuticals, LLC |
Substance Name | PHENTERMINE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC] |